Coherus discloses discounted biosimilar Udencya®

Nov 8, 2018

Coherus discloses newly approved biosimilar Udencya® will be available at a 33% discount to Neulasta®, matching the price point for Mylan’s biosimilar Fulphila®. The product is due to be launched on 3 January 2019.

Print Page Mail Article